News & Publications
Press Releases
-
NanOlogy Announces an Abstract Has Been Accepted for Presentation at the IASLC North America Conference on Lung Cancer
November 20, 2023 by NanOlogy
-
NanOlogy Announces an Abstract Has Been Accepted for Presentation at the 38th SITC Annual Meeting
October 23, 2023 by NanOlogy
-
Interim Results from a NanOlogy Phase 2 Clinical Trial of its Intratumoral Investigational Drug in the Treatment of Locally Advanced Pancreatic Cancer
October 10, 2023 by NanOlogy
-
NanOlogy Announces Two Abstracts Have Been Accepted for Presentation at AACR Special Conference in Cancer Research: Pancreatic Cancer
September 12, 2023 by NanOlogy
-
NanOlogy Presents Clinical Research at 2023 DDW and ASCO Involving its Large Surface Area Microparticle Investigational Drugs
June 7, 2023 by NanOlogy
NanOlogy in the News
-
OncLive: LSAM-PTX Demonstrates Disease Control, Safety in Locally Advanced Pancreatic Cancer
October 11, 2023 by Wilson PJ
-
OncLive: LSAM-DTX Effective and Safe in NMIBC Using Direct, Multifaceted Approach
September 16, 2021 by NanOlogy
-
Target Oncology: Direct and Multifaceted LSAM-DTX Treatment May Be Safe and Effective in NMIBC
September 16, 2021 by NanOlogy
-
JACS: Surgery is a viable treatment for pancreatic cancer patients especially after chemotherapy
March 26, 2021 by NanOlogy
-
Current Urology Reports: Current Clinical Trials in Non-muscle-Invasive Bladder Cancer: Heightened Need in an Era of Chronic BCG Shortage
January 9, 2020 by NanOlogy
Presentations
- SITC 2023 Poster: Local Administration of Large Surface Area Microparticle Docetaxel is Associated with Anti-tumor Immunomodulation Across Multiple Tumor Types
- AACR Pancreatic Cancer 2023 Poster: EUS-guided Local Administration of Large Surface Area Microparticle Paclitaxel with Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cncer: A Single Center Experience
- AACR Pancreatic Cancer 2023 Poster: Enhancing the Immune Response in Locally Advanced Pancreatic Cancer (LAPC) with Intratumoral Endoscopic Ultrasound-guided Fine Needle Injection of Large Surface Area Microparticle Paclitaxel (LSAM-PTX)
- ASCO 2023 Abstract: Safety of locally administered large surface area microparticle paclitaxel and docetaxel in combination with standard of care cancer therapies
- DDW 2023 Poster: Intracystic Injection of Large Surface Area Microparticle Paclitael for Chemoablation of Intraductal Papillary Mucinous Neoplasms: Insights from an Expanded Access Protocol
Publications
- Journal for ImmunoTherapy of Cancer: Local Administration of Large Surface Area Microparticle Docetaxel is Associated with Anti-tumor Immunomodulation Across Multiple Tumor Types
- Pancreas: Response of Locally Advanced Pancreatic Cancer to Intratumoral Injection of Large Surface Area Microparticle Paclitaxel – Initial Report of Safety and Clinical Outcome
- Cancers: The Role of Therapeutic Endoscopic Ultrasound in Pancreatic Cancer: An Endoscopic Oncologists Perspective
- Diagnostics: A Review of Endoscopic Ultrasound-Guided Chemoablative Techniques for Pancreatic Cystic Lesions
- Diagnostics: Pancreatic Cystic Neoplasms: Diagnosis and Management
Upcoming NanOlogy Events
Media Contacts
Opus Biotech Communications
Daniel Eramian 425-306-8716 danieleramian@comcast.net
Charles Craig 404-245-0591 charles.s.craig@gmail.com
